NMDRs are significant because they complicate the assessment of risk and safety for chemicals. Traditional risk assessments often assume monotonic relationships, leading to the belief that higher doses equate to greater effects, and vice versa. With NMDRs, low doses might have significant effects that are not predicted by high-dose testing. This can have profound implications for risk assessment and regulatory practices, especially for chemicals that exhibit endocrine-disrupting properties.
